198 related articles for article (PubMed ID: 15259392)
1. Predictors of cognitive change from preclinical to clinical Alzheimer's disease.
Jones S; Small BJ; Fratiglioni L; Backman L
Brain Cogn; 2002 Jul; 49(2):210-3. PubMed ID: 15259392
[TBL] [Abstract][Full Text] [Related]
2. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
[TBL] [Abstract][Full Text] [Related]
3. Cognitive deficits in preclinical Alzheimer's disease and vascular dementia: patterns of findings from the Kungsholmen Project.
Bäckman L; Small BJ
Physiol Behav; 2007 Sep; 92(1-2):80-6. PubMed ID: 17573076
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.
Squitti R; Bressi F; Pasqualetti P; Bonomini C; Ghidoni R; Binetti G; Cassetta E; Moffa F; Ventriglia M; Vernieri F; Rossini PM
Neurology; 2009 Jan; 72(1):50-5. PubMed ID: 19122030
[TBL] [Abstract][Full Text] [Related]
5. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline.
Boyle PA; Wilson RS; Aggarwal NT; Tang Y; Bennett DA
Neurology; 2006 Aug; 67(3):441-5. PubMed ID: 16894105
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
Suh GH; Ju YS; Yeon BK; Shah A
Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
[TBL] [Abstract][Full Text] [Related]
7. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
8. An abnormal "one-leg balance" test predicts cognitive decline during Alzheimer's disease.
Rolland Y; Abellan van Kan G; Nourhashemi F; Andrieu S; Cantet C; Guyonnet-Gillette S; Vellas B
J Alzheimers Dis; 2009; 16(3):525-31. PubMed ID: 19276547
[TBL] [Abstract][Full Text] [Related]
9. Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization.
Chodosh J; Seeman TE; Keeler E; Sewall A; Hirsch SH; Guralnik JM; Reuben DB
J Am Geriatr Soc; 2004 Sep; 52(9):1456-62. PubMed ID: 15341546
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging.
Kado DM; Karlamangla AS; Huang MH; Troen A; Rowe JW; Selhub J; Seeman TE
Am J Med; 2005 Feb; 118(2):161-7. PubMed ID: 15694902
[TBL] [Abstract][Full Text] [Related]
11. Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors.
Roselli F; Tartaglione B; Federico F; Lepore V; Defazio G; Livrea P
Clin Neurol Neurosurg; 2009 May; 111(4):327-30. PubMed ID: 19036496
[TBL] [Abstract][Full Text] [Related]
12. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease.
Soto ME; Andrieu S; Cantet C; Reynish E; Ousset PJ; Arbus C; Gillette-Guyonnet S; Nourhashémi F; Vellas B;
Dement Geriatr Cogn Disord; 2008; 26(2):109-16. PubMed ID: 18617740
[TBL] [Abstract][Full Text] [Related]
14. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons.
Wilson RS; Schneider JA; Bienias JL; Evans DA; Bennett DA
Arch Neurol; 2003 Apr; 60(4):539-44. PubMed ID: 12707067
[TBL] [Abstract][Full Text] [Related]
15. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study.
Amieva H; Jacqmin-Gadda H; Orgogozo JM; Le Carret N; Helmer C; Letenneur L; Barberger-Gateau P; Fabrigoule C; Dartigues JF
Brain; 2005 May; 128(Pt 5):1093-101. PubMed ID: 15774508
[TBL] [Abstract][Full Text] [Related]
16. Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort.
Hsiung GY; Alipour S; Jacova C; Grand J; Gauthier S; Black SE; Bouchard RW; Kertesz A; Loy-English I; Hogan DB; Rockwood K; Feldman HH
Dement Geriatr Cogn Disord; 2008; 25(6):483-90. PubMed ID: 18417973
[TBL] [Abstract][Full Text] [Related]
17. Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community.
Carcaillon L; Pérès K; Péré JJ; Helmer C; Orgogozo JM; Dartigues JF
Dement Geriatr Cogn Disord; 2007; 23(6):439-45. PubMed ID: 17476100
[TBL] [Abstract][Full Text] [Related]
18. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.
Galvin JE; Powlishta KK; Wilkins K; McKeel DW; Xiong C; Grant E; Storandt M; Morris JC
Arch Neurol; 2005 May; 62(5):758-65. PubMed ID: 15883263
[TBL] [Abstract][Full Text] [Related]
19. Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly.
Buchman AS; Boyle PA; Wilson RS; Tang Y; Bennett DA
Psychosom Med; 2007 Jun; 69(5):483-9. PubMed ID: 17556640
[TBL] [Abstract][Full Text] [Related]
20. Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin.
Blasko I; Knaus G; Weiss E; Kemmler G; Winkler C; Falkensammer G; Griesmacher A; Würzner R; Marksteiner J; Fuchs D
J Psychiatr Res; 2007 Oct; 41(8):694-701. PubMed ID: 16542679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]